The NHS is the UK's largest customer of medicines and medical technologies. In addition to delivering high-quality healthcare, it has a great role to play in strengthening the country's economy, contributing directly to the success of Britain's thriving life sciences sector. Close working between the NHS and industry – including devices, diagnostics, pharma and biotech companies, as well as some of the leading universities and research centres in the world – supports the ability of the UK to deliver health benefits to the public, patients and society.
Following the launch of the Life Sciences Strategy and the Innovation Health and Wealth report, Advances in Medical Science: collaboration for growth will be a showcase of the latest developments in medical science, offering an ideal opportunity for the science community, the NHS and their respective partners to come together to discuss innovative medicines and treatments for pressing health issues.
Following the launch of the Life Sciences Strategy and the Innovation Health and Wealth report, Advances in Medical Science: collaboration for growth will be a showcase of the latest developments in medical science, offering an ideal opportunity for the science community, the NHS and their respective partners to come together to discuss innovative medicines and treatments for pressing health issues.














